FMC North Alabama in Huntsville, Alabama - Dialysis Center

FMC North Alabama is a medicare approved dialysis facility center in Huntsville, Alabama and it has 22 dialysis stations. It is located in Madison county at 1311 N Memorial Pkwy #200, Huntsville, AL, 35801. You can reach out to the office of FMC North Alabama at (256) 536-8571. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC North Alabama has the following ownership type - Profit. It was first certified by medicare in July, 1979. The medicare id for this facility is 012509 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameFMC North Alabama
Location1311 N Memorial Pkwy #200, Huntsville, Alabama
No. of Dialysis Stations 22
Medicare ID012509
Managed ByFresenius Medical Care
Ownership TypeProfit
Late Shifts No

Contact Information


1311 N Memorial Pkwy #200, Huntsville, Alabama, 35801
(256) 536-8571

News Archive

Existing heart failure drug may be effective in treating postural orthostatic tachycardia syndrome

In a new study out of University of California San Diego School of Medicine, researchers found a drug used for heart failure improves symptoms associated with postural orthostatic tachycardia syndrome, otherwise known as POTS.

Finding could lead researchers to better understand development of psychiatric disorders

Some people take stress in stride; others are done in by it. New research at Rockefeller University has identified the molecular mechanisms of this so-called stress gap in mice with very similar genetic backgrounds - a finding that could lead researchers to better understand the development of psychiatric disorders such as anxiety and depression.

APP Pharmaceuticals receives FDA approval to market Ganciclovir for Injection, USP

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Ganciclovir for Injection, USP. Ganciclovir for Injection, USP is therapeutically equivalent to the reference-listed drug Cytovene-IV, which is marketed by Roche Laboratories, Inc.

Teen drinking increases the risk for breast cancer

What are the chances of you developing breast cancer if you have been drinking alcohol regularly as a teenager? Very high indeed as per the findings of a study called "Growing Up Today" conducted on 6,899 women from the time they were 9 to 15 year old till they turned 18 to 27 years old.

Read more Medical News

› Verified 6 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with FMC North Alabama from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1518069939
Organization NameNorth Alabama Nephrology Center
Doing Business AsBio-medical Applications Of Alabama, Inc.
Address1311 Memorial Pkwy Nw Huntsville, Alabama, 35801
Phone Number(256) 536-8571

News Archive

Existing heart failure drug may be effective in treating postural orthostatic tachycardia syndrome

In a new study out of University of California San Diego School of Medicine, researchers found a drug used for heart failure improves symptoms associated with postural orthostatic tachycardia syndrome, otherwise known as POTS.

Finding could lead researchers to better understand development of psychiatric disorders

Some people take stress in stride; others are done in by it. New research at Rockefeller University has identified the molecular mechanisms of this so-called stress gap in mice with very similar genetic backgrounds - a finding that could lead researchers to better understand the development of psychiatric disorders such as anxiety and depression.

APP Pharmaceuticals receives FDA approval to market Ganciclovir for Injection, USP

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Ganciclovir for Injection, USP. Ganciclovir for Injection, USP is therapeutically equivalent to the reference-listed drug Cytovene-IV, which is marketed by Roche Laboratories, Inc.

Teen drinking increases the risk for breast cancer

What are the chances of you developing breast cancer if you have been drinking alcohol regularly as a teenager? Very high indeed as per the findings of a study called "Growing Up Today" conducted on 6,899 women from the time they were 9 to 15 year old till they turned 18 to 27 years old.

Read more Medical News

› Verified 6 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data34
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL26

News Archive

Existing heart failure drug may be effective in treating postural orthostatic tachycardia syndrome

In a new study out of University of California San Diego School of Medicine, researchers found a drug used for heart failure improves symptoms associated with postural orthostatic tachycardia syndrome, otherwise known as POTS.

Finding could lead researchers to better understand development of psychiatric disorders

Some people take stress in stride; others are done in by it. New research at Rockefeller University has identified the molecular mechanisms of this so-called stress gap in mice with very similar genetic backgrounds - a finding that could lead researchers to better understand the development of psychiatric disorders such as anxiety and depression.

APP Pharmaceuticals receives FDA approval to market Ganciclovir for Injection, USP

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Ganciclovir for Injection, USP. Ganciclovir for Injection, USP is therapeutically equivalent to the reference-listed drug Cytovene-IV, which is marketed by Roche Laboratories, Inc.

Teen drinking increases the risk for breast cancer

What are the chances of you developing breast cancer if you have been drinking alcohol regularly as a teenager? Very high indeed as per the findings of a study called "Growing Up Today" conducted on 6,899 women from the time they were 9 to 15 year old till they turned 18 to 27 years old.

Read more Medical News

› Verified 6 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center79
    Adult patient months included in Kt/V greater than or equal to 1.2682
    Percentage of adult patients getting regular hemodialysis at the center94

    News Archive

    Existing heart failure drug may be effective in treating postural orthostatic tachycardia syndrome

    In a new study out of University of California San Diego School of Medicine, researchers found a drug used for heart failure improves symptoms associated with postural orthostatic tachycardia syndrome, otherwise known as POTS.

    Finding could lead researchers to better understand development of psychiatric disorders

    Some people take stress in stride; others are done in by it. New research at Rockefeller University has identified the molecular mechanisms of this so-called stress gap in mice with very similar genetic backgrounds - a finding that could lead researchers to better understand the development of psychiatric disorders such as anxiety and depression.

    APP Pharmaceuticals receives FDA approval to market Ganciclovir for Injection, USP

    APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Ganciclovir for Injection, USP. Ganciclovir for Injection, USP is therapeutically equivalent to the reference-listed drug Cytovene-IV, which is marketed by Roche Laboratories, Inc.

    Teen drinking increases the risk for breast cancer

    What are the chances of you developing breast cancer if you have been drinking alcohol regularly as a teenager? Very high indeed as per the findings of a study called "Growing Up Today" conducted on 6,899 women from the time they were 9 to 15 year old till they turned 18 to 27 years old.

    Read more Medical News

    › Verified 6 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC North Alabama with elevated calcium levels.

Patients with hypercalcemia84
Hypercalcemia patient months724
Patients with Serumphosphor86
Patients with Serumphosphor less than 3.5 mg/dL7
Patients with Serumphosphor from 3.5 to 4.5 mg/dL23
Patients with Serumphosphor from 4.6 to 5.5 mg/dL27
Patients with Serumphosphor from 5.6 to 7 mg/dL29
Patients with Serumphosphor greater than 7 mg/dL14

News Archive

Existing heart failure drug may be effective in treating postural orthostatic tachycardia syndrome

In a new study out of University of California San Diego School of Medicine, researchers found a drug used for heart failure improves symptoms associated with postural orthostatic tachycardia syndrome, otherwise known as POTS.

Finding could lead researchers to better understand development of psychiatric disorders

Some people take stress in stride; others are done in by it. New research at Rockefeller University has identified the molecular mechanisms of this so-called stress gap in mice with very similar genetic backgrounds - a finding that could lead researchers to better understand the development of psychiatric disorders such as anxiety and depression.

APP Pharmaceuticals receives FDA approval to market Ganciclovir for Injection, USP

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Ganciclovir for Injection, USP. Ganciclovir for Injection, USP is therapeutically equivalent to the reference-listed drug Cytovene-IV, which is marketed by Roche Laboratories, Inc.

Teen drinking increases the risk for breast cancer

What are the chances of you developing breast cancer if you have been drinking alcohol regularly as a teenager? Very high indeed as per the findings of a study called "Growing Up Today" conducted on 6,899 women from the time they were 9 to 15 year old till they turned 18 to 27 years old.

Read more Medical News

› Verified 6 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 79
Patient months included in arterial venous fistula and catheter summaries 518
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment66
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer12

News Archive

Existing heart failure drug may be effective in treating postural orthostatic tachycardia syndrome

In a new study out of University of California San Diego School of Medicine, researchers found a drug used for heart failure improves symptoms associated with postural orthostatic tachycardia syndrome, otherwise known as POTS.

Finding could lead researchers to better understand development of psychiatric disorders

Some people take stress in stride; others are done in by it. New research at Rockefeller University has identified the molecular mechanisms of this so-called stress gap in mice with very similar genetic backgrounds - a finding that could lead researchers to better understand the development of psychiatric disorders such as anxiety and depression.

APP Pharmaceuticals receives FDA approval to market Ganciclovir for Injection, USP

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Ganciclovir for Injection, USP. Ganciclovir for Injection, USP is therapeutically equivalent to the reference-listed drug Cytovene-IV, which is marketed by Roche Laboratories, Inc.

Teen drinking increases the risk for breast cancer

What are the chances of you developing breast cancer if you have been drinking alcohol regularly as a teenager? Very high indeed as per the findings of a study called "Growing Up Today" conducted on 6,899 women from the time they were 9 to 15 year old till they turned 18 to 27 years old.

Read more Medical News

› Verified 6 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary78
Hospitalization Rate in facility208.6 (As Expected)
Hospitalization Rate: Upper Confidence Limit340.1
Hospitalization Rate: Lower Confidence Limit131.4

News Archive

Existing heart failure drug may be effective in treating postural orthostatic tachycardia syndrome

In a new study out of University of California San Diego School of Medicine, researchers found a drug used for heart failure improves symptoms associated with postural orthostatic tachycardia syndrome, otherwise known as POTS.

Finding could lead researchers to better understand development of psychiatric disorders

Some people take stress in stride; others are done in by it. New research at Rockefeller University has identified the molecular mechanisms of this so-called stress gap in mice with very similar genetic backgrounds - a finding that could lead researchers to better understand the development of psychiatric disorders such as anxiety and depression.

APP Pharmaceuticals receives FDA approval to market Ganciclovir for Injection, USP

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Ganciclovir for Injection, USP. Ganciclovir for Injection, USP is therapeutically equivalent to the reference-listed drug Cytovene-IV, which is marketed by Roche Laboratories, Inc.

Teen drinking increases the risk for breast cancer

What are the chances of you developing breast cancer if you have been drinking alcohol regularly as a teenager? Very high indeed as per the findings of a study called "Growing Up Today" conducted on 6,899 women from the time they were 9 to 15 year old till they turned 18 to 27 years old.

Read more Medical News

› Verified 6 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at FMC North Alabama were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility27.3 (As Expected)
Readmission Rate: Upper Confidence Limit40.7
Readmission Rate: Lower Confidence Limit16.4

News Archive

Existing heart failure drug may be effective in treating postural orthostatic tachycardia syndrome

In a new study out of University of California San Diego School of Medicine, researchers found a drug used for heart failure improves symptoms associated with postural orthostatic tachycardia syndrome, otherwise known as POTS.

Finding could lead researchers to better understand development of psychiatric disorders

Some people take stress in stride; others are done in by it. New research at Rockefeller University has identified the molecular mechanisms of this so-called stress gap in mice with very similar genetic backgrounds - a finding that could lead researchers to better understand the development of psychiatric disorders such as anxiety and depression.

APP Pharmaceuticals receives FDA approval to market Ganciclovir for Injection, USP

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Ganciclovir for Injection, USP. Ganciclovir for Injection, USP is therapeutically equivalent to the reference-listed drug Cytovene-IV, which is marketed by Roche Laboratories, Inc.

Teen drinking increases the risk for breast cancer

What are the chances of you developing breast cancer if you have been drinking alcohol regularly as a teenager? Very high indeed as per the findings of a study called "Growing Up Today" conducted on 6,899 women from the time they were 9 to 15 year old till they turned 18 to 27 years old.

Read more Medical News

› Verified 6 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at FMC North Alabama get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility.18 (Better than Expected)
SIR: Upper Confidence Limit.87
SIR: Lower Confidence Limit.01

News Archive

Existing heart failure drug may be effective in treating postural orthostatic tachycardia syndrome

In a new study out of University of California San Diego School of Medicine, researchers found a drug used for heart failure improves symptoms associated with postural orthostatic tachycardia syndrome, otherwise known as POTS.

Finding could lead researchers to better understand development of psychiatric disorders

Some people take stress in stride; others are done in by it. New research at Rockefeller University has identified the molecular mechanisms of this so-called stress gap in mice with very similar genetic backgrounds - a finding that could lead researchers to better understand the development of psychiatric disorders such as anxiety and depression.

APP Pharmaceuticals receives FDA approval to market Ganciclovir for Injection, USP

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Ganciclovir for Injection, USP. Ganciclovir for Injection, USP is therapeutically equivalent to the reference-listed drug Cytovene-IV, which is marketed by Roche Laboratories, Inc.

Teen drinking increases the risk for breast cancer

What are the chances of you developing breast cancer if you have been drinking alcohol regularly as a teenager? Very high indeed as per the findings of a study called "Growing Up Today" conducted on 6,899 women from the time they were 9 to 15 year old till they turned 18 to 27 years old.

Read more Medical News

› Verified 6 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether FMC North Alabama's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 67
Transfusion Rate in facility57 (As Expected)
Transfusion Rate: Upper Confidence Limit119.1
Transfusion Rate: Lower Confidence Limit29.9

News Archive

Existing heart failure drug may be effective in treating postural orthostatic tachycardia syndrome

In a new study out of University of California San Diego School of Medicine, researchers found a drug used for heart failure improves symptoms associated with postural orthostatic tachycardia syndrome, otherwise known as POTS.

Finding could lead researchers to better understand development of psychiatric disorders

Some people take stress in stride; others are done in by it. New research at Rockefeller University has identified the molecular mechanisms of this so-called stress gap in mice with very similar genetic backgrounds - a finding that could lead researchers to better understand the development of psychiatric disorders such as anxiety and depression.

APP Pharmaceuticals receives FDA approval to market Ganciclovir for Injection, USP

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Ganciclovir for Injection, USP. Ganciclovir for Injection, USP is therapeutically equivalent to the reference-listed drug Cytovene-IV, which is marketed by Roche Laboratories, Inc.

Teen drinking increases the risk for breast cancer

What are the chances of you developing breast cancer if you have been drinking alcohol regularly as a teenager? Very high indeed as per the findings of a study called "Growing Up Today" conducted on 6,899 women from the time they were 9 to 15 year old till they turned 18 to 27 years old.

Read more Medical News

› Verified 6 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at FMC North Alabama lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary479
Mortality Rate in facility19.7 (As Expected)
Mortality Rate: Upper Confidence Limit25.3
Mortality Rate: Lower Confidence Limit15.1

News Archive

Existing heart failure drug may be effective in treating postural orthostatic tachycardia syndrome

In a new study out of University of California San Diego School of Medicine, researchers found a drug used for heart failure improves symptoms associated with postural orthostatic tachycardia syndrome, otherwise known as POTS.

Finding could lead researchers to better understand development of psychiatric disorders

Some people take stress in stride; others are done in by it. New research at Rockefeller University has identified the molecular mechanisms of this so-called stress gap in mice with very similar genetic backgrounds - a finding that could lead researchers to better understand the development of psychiatric disorders such as anxiety and depression.

APP Pharmaceuticals receives FDA approval to market Ganciclovir for Injection, USP

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Ganciclovir for Injection, USP. Ganciclovir for Injection, USP is therapeutically equivalent to the reference-listed drug Cytovene-IV, which is marketed by Roche Laboratories, Inc.

Teen drinking increases the risk for breast cancer

What are the chances of you developing breast cancer if you have been drinking alcohol regularly as a teenager? Very high indeed as per the findings of a study called "Growing Up Today" conducted on 6,899 women from the time they were 9 to 15 year old till they turned 18 to 27 years old.

Read more Medical News

› Verified 6 days ago


Dialysis Facility in Huntsville, AL

FMC North Alabama
Location: 1311 N Memorial Pkwy #200, Huntsville, Alabama, 35801
Phone: (256) 536-8571
FMC Huntsville
Location: 2325 Pansy Street, Huntsville, Alabama, 35801
Phone: (256) 536-1881
FMC Parkway
Location: 1311 N Memorial Pkwy Ste 100, Huntsville, Alabama, 35801
Phone: (256) 536-5563
FMC Chase
Location: 1849 Keats Drive Northwest, Huntsville, Alabama, 35810
Phone: (256) 852-8900
FMC Discovery
Location: 1131 Eagletree Ln, Ste100, Huntsville, Alabama, 35801
Phone: (256) 489-4160

News Archive

Existing heart failure drug may be effective in treating postural orthostatic tachycardia syndrome

In a new study out of University of California San Diego School of Medicine, researchers found a drug used for heart failure improves symptoms associated with postural orthostatic tachycardia syndrome, otherwise known as POTS.

Finding could lead researchers to better understand development of psychiatric disorders

Some people take stress in stride; others are done in by it. New research at Rockefeller University has identified the molecular mechanisms of this so-called stress gap in mice with very similar genetic backgrounds - a finding that could lead researchers to better understand the development of psychiatric disorders such as anxiety and depression.

APP Pharmaceuticals receives FDA approval to market Ganciclovir for Injection, USP

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Ganciclovir for Injection, USP. Ganciclovir for Injection, USP is therapeutically equivalent to the reference-listed drug Cytovene-IV, which is marketed by Roche Laboratories, Inc.

Teen drinking increases the risk for breast cancer

What are the chances of you developing breast cancer if you have been drinking alcohol regularly as a teenager? Very high indeed as per the findings of a study called "Growing Up Today" conducted on 6,899 women from the time they were 9 to 15 year old till they turned 18 to 27 years old.

Read more Medical News

› Verified 6 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.